A new CRISPR-based diagnostic test is using "nanocircles" of DNA to enhance sensitivity without requiring specialized DNA or RNA preamplification, which could allow for more rapid diagnosis and cheaper test components that could potentially replace traditional PCR methods, according to a study in Nature Communications. The researchers are now focusing on overcoming the challenge of simultaneously detecting multiple targets, which is often required for medical applications.